Live

Watch CBSN Live

FDA and Biogen's push to accelerate approval of Alzheimer's drug

A new report by STAT is shedding light on the FDA's recent approval of the controversial Alzheimer's drug Aduhelm. Reporter Damian Garde joined CBSN to discuss what his investigation uncovered.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.